‘In It For The Long Haul‘ – Celltrion Remains Committed To US Biosimilars

Chief Commercial Officer Talks Humira Competition And Future Launch Plans

 
• By David Wallace
  
Celltrion logo on smartphone
Celltrion says it is committed to the US biosimilars market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products